A groundbreaking RNA therapy project at McGill University, led by Professor Carl Ernst, is exploring a potential treatment for Schinzel-Giedion Syndrome (SGS) by targeting the SETBP1 mutation. The research represents an exciting step toward developing a treatment that could address the underlying cause of SGS. 

Read the full article on McGill University’s website → https://www.mcgill.ca/dna-to-rna/article/hope-strand-rna-research-offers-chance-battle-against-schinzel-giedion-syndrome